KOLIBRI is a venture-backed biotech start-up. We aim to unlock the potential of gene therapies, by revolutionizing the way they are being manufactured.
Viral vector manufacturing remains the blocking point to scale up and make gene therapies more affordable and accessible.
To that end, KOLIBRI makes large-scale viral vector manufacturing 10x cheaper and with a higher quality combining cutting edge techniques in chemical optimisation and acoustics.
STATION F Job board is always looking for great talent. Go ahead and send an application!